Symbol Name ID |
Il13
interleukin 13 MGI:96541 |
* | Aspects of the system are reported to show a normal phenotype. |
Darker colors indicate more annotations |
Human Phenotypes | Cutaneous mastocytosis |
Allergic rhinitis |
Conjunctivitis |
Lymphadenopathy |
Hepatosplenomegaly |
Peritoneal abscess |
Eczematoid dermatitis |
Atopic dermatitis |
Recurrent skin infections |
Asthma |
Disease(s) Associated with IL13 | ||||||||||
asthma | ||||||||||
atopic dermatitis | ||||||||||
mastocytosis | ||||||||||
pancreatic cancer |
Mouse Phenotypes | immune system phenotype |
abnormal dendritic cell differentiation |
ileum inflammation |
abnormal T-helper 2 cell differentiation |
decreased eosinophil cell number |
increased eosinophil cell number |
cutaneous mastocytosis |
decreased T-helper 2 cell number |
increased T-helper 2 cell number |
decreased macrophage cell number |
abnormal leukocyte physiology |
impaired eosinophil recruitment |
impaired neutrophil recruitment |
decreased IgE level |
increased IgE level |
decreased IgG1 level |
increased IgG1 level |
increased IgG2a level |
increased IgG2b level |
decreased IgG level |
increased IgM level |
abnormal T-helper 2 physiology |
abnormal macrophage physiology |
abnormal splenocyte physiology |
decreased circulating interleukin-13 level |
abnormal chemokine level |
abnormal immune system physiology |
abnormal dendritic cell antigen presentation |
abnormal type I hypersensitivity reaction |
increased susceptibility to type I hypersensitivity reaction |
abnormal antigen presentation |
decreased interferon-gamma secretion |
increased interferon-gamma secretion |
abnormal interleukin secretion |
decreased interleukin-10 secretion |
decreased interleukin-13 secretion |
increased interleukin-13 secretion |
abnormal interleukin-4 secretion |
decreased interleukin-4 secretion |
increased interleukin-4 secretion |
decreased interleukin-5 secretion |
decreased interleukin-9 secretion |
decreased susceptibility to autoimmune disorder |
decreased susceptibility to experimental autoimmune encephalomyelitis |
granulomatous inflammation |
decreased inflammatory response |
respiratory system inflammation |
dermatitis |
abnormal susceptibility to infection |
decreased susceptibility to bacterial infection |
decreased susceptibility to parasitic infection induced morbidity/mortality |
increased susceptibility to parasitic infection induced morbidity/mortality |
decreased susceptibility to parasitic infection |
increased susceptibility to parasitic infection |
abnormal response to transplant |
increased length of allograft survival |
|
Availability | Mouse Genotype | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Il13tm1.1Anjm/Il13tm1.1Anjm | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Il13tm1Anjm/Il13tm1Anjm | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Il13tm2Anjm/Il13tm2Anjm | * | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tg(KRT5-tTA)1216Glk/0 Tg(tetO-Il13)1Tazh/0 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tg(Scgb1a1-Il13)2Eli/? |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 05/28/2024 MGI 6.13 |
|
|